€21.05
0.00% yesterday
Brüssel, Sep 09, 05:35 pm CET
ISIN
BE0003874915
Symbol
FAGR

Fagron SA Stock price

€21.05
+0.15 0.72% 1M
+2.43 13.05% 6M
+4.29 25.60% YTD
+1.87 9.75% 1Y
+7.90 60.08% 3Y
+1.26 6.37% 5Y
+2.25 11.94% 10Y
+11.10 111.56% 20Y
Brüssel, Closing price Tue, Sep 09 2025
+0.00 0.00%
ISIN
BE0003874915
Symbol
FAGR

Key metrics

Basic
Market capitalization
€1.5b
Enterprise Value
€1.9b
Net debt
€314.1m
Cash
€89.3m
Shares outstanding
73.1m
Valuation (TTM | estimate)
P/E
17.8 | 15.5
P/S
1.7 | 1.6
EV/Sales
2.0 | 1.9
EV/FCF
21.8
P/B
3.1
Dividends
DPS
€0.35
Yield 1Y | 5Y
1.7% | 1.5%
Growth 1Y | 5Y
16.7% | 34.3%
Payout 1Y | 3Y
27.3% | 24.8%
Increased
5 Years
Financials (TTM | estimate)
Revenue
€918.8m | €961.6m
EBITDA
€184.3m | €195.2m
EBIT
€140.3m | €149.0m
Net Income
€85.7m | €99.1m
Free Cash Flow
€85.0m
Growth (TTM | estimate)
Revenue
11.9% | 10.3%
EBITDA
15.4% | 15.1%
EBIT
17.3% | 11.7%
Net Income
9.9% | 23.0%
Free Cash Flow
-0.3%
Margin (TTM | estimate)
Gross
45.8%
EBITDA
20.1% | 20.3%
EBIT
15.3%
Net
9.3% | 10.3%
Free Cash Flow
9.3%
Financial Health
Equity Ratio
46.3%
Return on Equity
16.1%
ROCE
15.4%
ROIC
12.4%
Debt/Equity
0.8
More
EPS
€1.2
FCF per Share
€1.2
Short interest
-
Employees
4k
Rev per Employee
€220.0k
Show more

Is Fagron SA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,018 stocks worldwide.

Fagron SA Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Fagron SA forecast:

12x Buy
92%
1x Hold
8%

Analyst Opinions

13 Analysts have issued a Fagron SA forecast:

Buy
92%
Hold
8%

Financial data from Fagron SA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
919 919
12% 12%
100%
- Direct Costs 498 498
9% 9%
54%
420 420
16% 16%
46%
- Selling and Administrative Expenses 237 237
16% 16%
26%
- Research and Development Expense - -
-
-
184 184
15% 15%
20%
- Depreciation and Amortization 44 44
10% 10%
5%
EBIT (Operating Income) EBIT 140 140
17% 17%
15%
Net Profit 86 86
10% 10%
9%

In millions EUR.

Don't miss a Thing! We will send you all news about Fagron SA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 3,989 full-time employees. The company went IPO on 2007-10-05. The firm specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The company operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.

Head office Belgium
Employees 3,989
Website fagron.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today